海创药业-U
(688302)
| 流通市值：30.21亿 | | | 总市值：30.21亿 |
| 流通股本：9901.56万 | | | 总股本：9901.56万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 54,970,550.02 | 26,025,486.34 | 20,469,871.8 | 23,351,806.02 |
| 营业总成本 | 122,243,112.65 | 61,436,387.58 | 187,696,021.58 | 142,363,467.94 |
| 其他经营收益 | | | | |
| 营业利润 | -54,747,096.83 | -29,472,662.99 | -136,359,631.59 | -98,547,620.62 |
| 利润总额 | -56,215,027.84 | -29,878,860.64 | -137,249,571.37 | -99,144,115.46 |
| 净利润 | -56,218,129.78 | -29,881,987.83 | -137,252,611.25 | -99,147,164.4 |
| 每股收益 | | | | |
| 其他综合收益 | -139,521.46 | -70,018.53 | -117,308.03 | -69,763.02 |
| 综合收益总额 | -56,357,651.24 | -29,952,006.36 | -137,369,919.28 | -99,216,927.42 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 856,284,990.45 | 880,831,831.06 | 906,337,365.95 | 975,439,863.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 416,779,116.82 | 405,048,710.01 | 403,408,875.01 | 387,749,679.37 |
| 资产总计 | 1,273,064,107.27 | 1,285,880,541.07 | 1,309,746,240.96 | 1,363,189,542.68 |
| 流动负债: | | | | |
| 流动负债合计 | 138,723,848.3 | 125,079,803.43 | 125,904,332.92 | 141,352,583.49 |
| 非流动负债: | | | | |
| 非流动负债合计 | 126,869,481.24 | 127,043,329.85 | 120,283,189.67 | 120,919,272.51 |
| 负债合计 | 265,593,329.54 | 252,123,133.28 | 246,187,522.59 | 262,271,856 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,007,470,777.73 | 1,033,757,407.79 | 1,063,558,718.37 | 1,100,917,686.68 |
| 股东权益合计 | 1,007,470,777.73 | 1,033,757,407.79 | 1,063,558,718.37 | 1,100,917,686.68 |
| 负债和股东权益合计 | 1,273,064,107.27 | 1,285,880,541.07 | 1,309,746,240.96 | 1,363,189,542.68 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 71,021,744.43 | 48,579,005.61 | 70,931,053.46 | 54,496,375.19 |
| 经营活动现金流出小计 | 117,415,822.19 | 59,706,991.14 | 179,809,341.94 | 134,205,347.09 |
| 经营活动产生的现金流量净额 | -46,394,077.76 | -11,127,985.53 | -108,878,288.48 | -79,708,971.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 963,462,734.84 | 541,412,016.64 | 2,528,232,456.83 | 1,917,388,453.78 |
| 投资活动现金流出小计 | 1,034,626,555.81 | 528,234,114.79 | 2,667,936,135.81 | 2,136,063,215.07 |
| 投资活动产生的现金流量净额 | -71,163,820.97 | 13,177,901.85 | -139,703,678.98 | -218,674,761.29 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 100,000,000 | 100,000,000 |
| 筹资活动现金流出小计 | 3,338,173.66 | 1,607,631.36 | 4,759,329.7 | 3,356,165.25 |
| 筹资活动产生的现金流量净额 | -3,338,173.66 | -1,607,631.36 | 95,240,670.3 | 96,643,834.75 |
| 汇率变动对现金及现金等价物的影响 | -3,480,461.43 | -1,698,760.99 | -2,294,393.72 | -1,084,227.63 |
| 现金及现金等价物净增加额 | -124,376,533.82 | -1,256,476.03 | -155,635,690.88 | -202,824,126.07 |
| 期末现金及现金等价物余额 | 313,213,831.79 | 436,333,889.58 | 437,590,365.61 | 390,401,930.42 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -124,376,533.82 | - | -155,635,690.88 | - |
最新报告期：2026-08-27| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西南证券 | 杜向阳 | -1.22 | 0.15 | 1.41 | 2026-08-27 |
| 国投证券 | 冯俊曦,连国强 | -1.05 | 0.33 | 1.46 | 2026-07-21 |